{
  "id": "27fba67d-1e26-4c29-8df2-95cf12aa00c1",
  "answer": "Liminatus Pharma, Inc. Class A Common Stock has a balanced company news read. Its latest completed weekly trend is negative.",
  "status": "balanced",
  "as_of": "2026-08-16T02:08:05.183009+00:00",
  "period_end": "2026-08-14",
  "scope": "company and instrument",
  "subject": {
    "type": "ticker",
    "key": "NASDAQ:LIMN",
    "name": "Liminatus Pharma, Inc. Class A Common Stock (LIMN)",
    "identity": {
      "sharemaestro_id": "b5fd8ad1-8781-46c7-8f7d-d55f3271cea4",
      "canonical_name": "Liminatus Pharma, Inc. Class A Common Stock",
      "isin": null,
      "lei": null,
      "cik": null,
      "website": null,
      "aliases": [
        "LIMN"
      ],
      "provider_symbols": {
        "eodhd": [
          "LIMN.US"
        ],
        "yahoo": "LIMN",
        "market": "NASDAQ",
        "alpha_vantage": "LIMN"
      },
      "same_as": []
    }
  },
  "coverage": {
    "country": "United States",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "score": 50.0,
  "confidence": 25,
  "evidence_count": 21,
  "independent_sources": 1,
  "freshest_evidence": "2026-08-14T20:51:48+00:00",
  "previous_read": 50.0,
  "change": 0.0,
  "method_version": "public-evidence-1",
  "facts": {
    "sector": "Healthcare",
    "ticker": "LIMN",
    "company": "Liminatus Pharma, Inc. Class A Common Stock",
    "country": "United States",
    "currency": "USD",
    "exchange": "NASDAQ",
    "industry": "Biotechnology",
    "week_end": "2026-08-14",
    "asset_type": "equity",
    "news_count": 21,
    "trend_state": "negative",
    "latest_close": "0.140000",
    "score_change": 0.0,
    "weekly_change": 35.922,
    "evidence_status": "provisional",
    "sentiment_score": 50
  },
  "canonical_url": "https://sharemaestro.com/evidence/27fba67d-1e26-4c29-8df2-95cf12aa00c1/",
  "evidence_urls": [
    {
      "label": "Company chart",
      "url": "https://sharemaestro.com/terminal/b5fd8ad1-8781-46c7-8f7d-d55f3271cea4/"
    },
    {
      "label": "Company news sentiment",
      "url": "https://sharemaestro.com/sentiment/b5fd8ad1-8781-46c7-8f7d-d55f3271cea4/"
    },
    {
      "label": "Current financial news",
      "url": "https://sharemaestro.com/newsreel/search/?ticker=LIMN"
    }
  ],
  "limitations": "This is dated market research. Coverage may be delayed, incomplete or unavailable.",
  "record_hash": "f8aa0602c33b2438a06eabf08890f0b44e8f77eaa992825b9ced95521f9a9425",
  "citation": "Sharemaestro, Liminatus Pharma, Inc. Class A Common Stock (LIMN), 2026-08-16, https://sharemaestro.com/evidence/27fba67d-1e26-4c29-8df2-95cf12aa00c1/"
}